Ingevity (NYSE: NGVT) reported Q2 EPS of $1.41, $0.04 better than the analyst estimate of $1.37. Revenue for the quarter came in at $481.8 million versus the consensus estimate of $486.43 million.

GUIDANCE:

Ingevity sees FY2023 revenue of $1.6-1.7 billion, and adjusted EBITDA between $390 million and $420 million.

For earnings history and earnings-related data on Ingevity (NGVT) click here.